Tablet-based Patient Reported Outcome

Pilot Study for Tablet-based Questionnaire of Patient-reported Outcomes From Patients Undergoing Chemotherapy (TabPRO I)

This study is a single arm feasibility study. Patients that have been diagnosed with carcinoma and are undergoing chemotherapy have to document chemotherapy associated side effects on a regular basis by means of a tablet-based online questionnaire. Goal of the study is to find out if patients that are undergoing chemotherapy are willing to document chemotherapy associated side effects by means of a tablet-based online questionnaire.

Inclusion Criteria:

• patients have to be ≥ 18 years of age
• written consent form and agreement to participate in the study
• patients that are able to follow the study instructions and that most likely will keep the required study appointments
• patients that have a histological confirmed carcinoma and are scheduled to undergo adjuvant or neoadjuvant chemotherapy of 6 to 8 cycles
• questions about chemotherapy associated side effects are composed in german. Therefore the study participants must have sufficient knowledge of the german language
• ECOG maximal level 2

Exclusion Criteria:

• patients that are younger than 18 years
• patients that don't agree to take part of the study
• patients that are not able to understand the scope, the meaning and the consequences of that clinical study
• patients that have a known or constant addiction to drugs or alcohol
• patients that suffer from blindness or dyslexia